Schedule 13G ownership disclosure
Benitec Biopharma Inc
Security class unavailable · CUSIP: 08205P209
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 180,399
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000053
- Form type
- SC 13G
- Filer
- Benitec Biopharma Inc.
- CIK
- CIK 1808898
- Filed
- Feb 13, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership